Does CMS Hate Specialists?

Key Takeaways

• Medicare reimbursement for joint replacements fell 57% in 20 years
• New CMMI models place specialists under primary‑care‑led accountability
• Studies show specialist‑led bundles cut costs and improved outcomes
• Shifting risk away from surgeons may hinder effective care coordination
• Leveraging surgeons in chronic‑disease prevention could enhance value

Pulse Analysis

Medicare’s evolving payment landscape has dramatically reshaped orthopedic practice. Over the past 20 years, inflation‑adjusted fees for joint replacements have dropped more than half, a trend accelerated by the 2026 fee‑schedule’s 2.5% efficiency cut. While value‑based care promises better outcomes, CMS’s newest CMMI initiatives—ACCESS, TEAM, ACO LEAD and CJR‑X—relegate specialists to peripheral roles, assigning accountability to primary‑care‑led organizations that often lack the granular clinical insight needed for complex surgical decisions. This structural shift raises concerns about whether cost savings are truly sustainable or merely the byproduct of reduced specialist involvement.

Empirical data from bundled‑payment experiments challenges CMS’s assumptions. A JAMA analysis of 91 orthopedic groups in the BPCI Model 2 demonstrated lower Medicare payments and unchanged patient complexity, driven by reduced post‑acute service utilization—a metric best managed by surgeons. Similarly, physician‑group practices saved an average of $240 per episode compared with hospitals, underscoring the financial and clinical advantages of specialist‑centered accountability. When surgeons retain clinical authority while sharing financial risk, they can align pre‑operative optimization, intra‑operative efficiency, and post‑acute pathways, delivering measurable savings without compromising care quality.

Looking forward, the most effective path may involve integrating surgeons as leaders of chronic‑disease prevention rather than sidelining them. Programs like Duke’s Joint Health Initiative illustrate how specialty expertise can serve as a gateway to broader health interventions, encouraging patients to address comorbidities such as diabetes or hypertension before surgery. By granting surgeons both clinical and financial stewardship, CMS could harness their unique position to drive holistic value, improve patient outcomes, and sustain Medicare’s fiscal health. Ignoring this potential risks perpetuating an accountability trap that undermines both cost containment and the quality of joint replacement services.